A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors

Name: A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors
Published: 2009
License: Public Domain

National Cancer Institute (NCI) · 2009

ClinicalTrials.gov · Datasets · License: Public Domain · 2009

Open Source ↗

brain-tumor pediatric

medulloblastoma, pontine glioma, ependymoma, astrocytoma, pnet, brain tumor, cnc tumor, pediatric, parp inhibitor, oral chemotherapy, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors

Related documents